DRAMAMINE (DIMENHYDRINATE) TABLET [NAVAJO MANUFACTURING COMPANY INC.]

DRAMAMINE (DIMENHYDRINATE) TABLET [NAVAJO MANUFACTURING COMPANY INC.]
PDF | XML

NDC 67751-170-01, 67751-170-02
Set ID 4139b5bf-2e49-40c3-9f4a-d8e15c044ead
Category HUMAN OTC DRUG LABEL
Packager Navajo Manufacturing Company Inc.
Generic Name
Product Class
Product Number
Application Number PART336
  • Drug Facts

  • Active ingredient (in each tablet)

    Dimenhydrinate 50 mg

    Purpose

    Antiemetic

  • Use

    for prevention and treatment of these symptoms associated with motion sickness:
    • nausea • vomiting • dizziness

  • Warnings

    Do not use 

    for children under 2 years of age unless directed by a doctor

    Ask a doctor before use if you have

    • a breathing problem such as emphysema or chronic bronchitis
    • glaucoma
    • trouble urinating due to an enlarged prostate gland

    Ask a doctor or pharmacist before use if 

    you are taking sedatives or tranquilizers

    When using this product

    • marked drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery

    If pregnant or breast-feeding,

    ask a doctor before use.

    Keep out of reach of children.

    In case of accidental overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

  • Directions

    to prevent motion sickness, the first dose should be taken 1/2 to 1 hour before starting activity
    to prevent or treat motion sickness:

     adults and children 12 years and over

    • take 1 to 2 chewable tablets every 4-6 hours 

    • do not take more than 8 chewable tablets in 24 hours, or as directed by a doctor

     children 6 to under 12 years

    • give 1/2 to 1 chewable tablet every 6-8 hours

    • do not give more than 3 chewable tablets in 24 hours, or as directed by a doctor

     children 2 to under 6 years

    • give 1/2 chewable tablet every 6-8 hours

    • do not give more than 1-1/2 chewable tablets in 24 hours, or as directed by a doctor

  • Other information

    Phenylketonurics: contains phenylalanine 0.75 mg per tablet
    • store at room temperature 20º-25ºC (68º- 77ºF)
    • do not use if pouch is opened
    • see pouch for lot number and expiration date

  • Inactive ingredients

    anhydrous citric acid, aspartame, FD&C yellow #6 aluminum lake, flavors, magnesium stearate, maltodextrin, methacrylic acid copolymer, modified starch, sorbitol

  • Questions or comments?

    call 1-800-382-7219

  • Package Labeling:

    Dramamine

  • INGREDIENTS AND APPEARANCE
    DRAMAMINE 
    dimenhydrinate tablet
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:67751-170(NDC:63029-901)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DIMENHYDRINATE (UNII: JB937PER5C) (DIPHENHYDRAMINE - UNII:8GTS82S83M) DIMENHYDRINATE50 mg
    Inactive Ingredients
    Ingredient NameStrength
    ANHYDROUS CITRIC ACID (UNII: XF417D3PSL)  
    ASPARTAME (UNII: Z0H242BBR1)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    SORBITOL (UNII: 506T60A25R)  
    Product Characteristics
    ColororangeScore2 pieces
    ShapeROUNDSize8mm
    FlavorORANGEImprint Code
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:67751-170-011 in 1 CARTON09/23/2016
    12 in 1 POUCH; Type 0: Not a Combination Product
    2NDC:67751-170-021 in 1 CARTON09/23/2016
    24 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph finalpart33609/23/2016
    Labeler - Navajo Manufacturing Company Inc. (091917799)
    Establishment
    NameAddressID/FEIBusiness Operations
    Navajo Manufacturing Company Inc.136941411relabel(67751-170) , repack(67751-170)

Related Drugs